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Abstract

Data Available

Re-sampling Techniques

Cerebral necrosis after radiation theraphy for patients with
brain metastases is being recognized as a problem more
common than previously estimated.

Data that was utilized during this project was contributed by
Radiation Oncology Department at UCSF Medical. It consisted
of features of over 10,000 metastases as well as over 2,000
patients.

In this project, the explored re-sampling algorithms included
Random Under-sampling, Cluster Centroids Under-sampling
(CC), Random Over-sampling, Synthetic Minority Oversampling (SMOTE) and combination sampling (SME). The
model performances with selected re-sampling methods were
shown in Table 1.

The initial goal of this project is trying to develop a diagnosis
model with machine learning techniques to predict the onset
of necrosis in order to improve current diagnosis. And the
ultimate goal is to better understand the onset of necrosis,
reduce its occurrence and generate general guides on
radiation therapy dose value for metastases treatment.

Introduction

Brain metastases, or secondary brain tumors are cancer cells
that spread from their original site to the brain. They are the
most common malignancy occurring within the cranium. In
America, about 25% of cancer patients suffered from
secondary brain tumors [1].
Treatment of brain metastases is multidisciplinary with
radiation forming the cornerstone[2]. However, significant risks
are accompanied by radiation therapy.
Cerebral necrosis, which is one of these, is the unnatural death
of the cells in an organ or tissue surrounding the tumor. Given
that its characteristics on standard imaging are no different
that tumor recurrence, traditional diagnosis of necrosis is
time-consuming and challenging.
The goal of this project is to leverage the plentiful information
of patient data to identify the patients with a higher risk for
radiation necrosis, and consequently lead to more effective
treatment strategies for brain metastases patients.
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Data preprocessing included feature selection, category
encoding and missing value imputation. The date information
of patient surgeries was dropped and instead, patient age was
calculated; one-hot encoding was applied to represent
different tumor primary sites; and since most of the
numerical inputs are boolean or discrete, missing values were
imputed by mode.

Models Exploration
Since it is a classificaiton problem, three baseline models were
explored, including Logistics Regression, Random Forest and
Gradient Boosting. After hyperparameter tuning , those three
models could archieve negative log-loss of .56, .52 and .43
respectively.
Noticing the fact that the dataset was significantly unbalanced,
with over 80% of patients labeling as non-necrosis, we felt the
need to adjust the class distribution of our dataset. One
technique was under-sampling the majority class, which was
the patients without necrosis in this case. Another technique
was over-sampling the minority class, which was the patients
with necrosis.
Table 1. Model Performances - Log-loss (AUC).

Logistics
Regression

Random Forest

Gradient Boosting

Under-sampling

.90 (.72)

.65 (.81)

.67 (.79)

CC

.63 (.78)

9.83 (.63)

.69 (.72)

SMOTE

.49 (.80)

.38 (.82)

.21 (.83)

SME

.71 (.79)

.71 (.80)

.33 (.80)

Generally speaking, SMOTE outperformed the other resampling methods. With data re-sampled by SMOTE, a
Gradient Boosting model could achieve a log-loss of .21 and
an AUC score of .83. Compared to the baseline models, the
model performance was improved significantly by re-sampling.
Cross-validation was then conducted to tun hyper-parametes
and to validate the model performance. The mean ROC curve
after 5 fold cross-validation was shown in Figure 1.

Figure 1. Mean ROC curve of SMOTE Model.

Figure 2. Confusion Matrix of SMOTE Model .

Discussion and Conclusions
As shown in Figure 2., the model had achieve an accuracy of 93%. It
performed well in predicting non-necrosis but it still need to be
improved to identify necrosis patients.
As suggested by the important features of the model, one possible
reason of the vague prediction on necrosis was lacking important
information about each metastasis. Current available data was only
patient-level. Next step of this project will be collecting metastasislevel data , exploring weighted techniques to handle unbalanced data
and then generating suggested radiotherapy dose value for
metastases treatment.
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